Form 8-K GLOBUS MEDICAL INC For: May 02
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Globus Medical (GMED) PT Raised to $58 at Needham & Company
May 3, 2018 6:38 AM EDTNeedham & Company raised its price target on Globus Medical (NYSE: GMED) to $58.00 (from $57.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "GMED's 1Q18 revenue and EPS beat consensus and management raised its 2018 revenue and EPS guidance. The guidance increases were... More

